LINCOLN

LINCOLN PHARMACEUTICALS

Small Cap BSE: 531633 NSE: LINCOLN
₹281.9
5.7 (2.06%)
As on 30 September, 2022 | 02:45

Lincoln Pharmaceuticals Share Price

Lincoln Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in LINCOLN PHARMACEUTICALS

Start SIP

Lincoln Pharmaceuticals Share Returns

  • Over 1 Month -0.97%
  • Over 3 Month -5.22%
  • Over 6 Month -9.76%
  • Over 1 Year -27.83%

Lincoln Pharmaceuticals Key Statistics

P/E Ratio 8.5
PEG Ratio 1.4
Market Cap Cr 565
Price to Book Ratio 1.3
EPS 34.3
Dividend 0.5
Relative Strength Index 43.14
Money Flow Index 51.8
MACD Signal -1.86
Average True Range 9.44

Lincoln Pharmaceuticals Investment Rating

  • Master Rating:
  • Lincoln Pharmaceuticals has an operating revenue of Rs. 427.83 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 20% is great, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 71 which is a FAIR score but needs to improve its earnings, a RS Rating of 15 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lincoln Pharmaceuticals Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 12310312012612078
Operating Expenses Qtr Cr 1078596979663
Operating Profit Qtr Cr 171723282414
Depreciation Qtr Cr 222211
Interest Qtr Cr 010001
Tax Qtr Cr 666773
Net Profit Qtr Cr 151118231712

Lincoln Pharmaceuticals Technicals

EMA & SMA

Current Price
280.75
4.55 (1.65%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 287.28
  • 50 Day
  • 291.73
  • 100 Day
  • 298.64
  • 200 Day
  • 315.48
  • 20 Day
  • 288.93
  • 50 Day
  • 294.06
  • 100 Day
  • 293.41
  • 200 Day
  • 315.39

Lincoln Pharmaceuticals Resistance and Support

PIVOT
₹277.09
Resistance
First Resistance 279.12
Second Resistance 282.04
Third Resistance 284.07
RSI 43.14
MFI 51.8
MACD Single Line -1.86
MACD -3.21
Support
First Resistance 274.17
Second Resistance 272.14
Third Resistance 269.22

Lincoln Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 15,712 926,222 58.95
Week 22,729 1,422,823 62.6
1 Month 40,212 2,284,061 56.8
6 Month 46,142 2,649,035 57.41

Lincoln Pharmaceuticals Result Highlights

Lincoln Pharmaceuticals Synopsis

NSE-Medical-Diversified

Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 472.08 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2022. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.
Market Cap 562
Sales 472
Shares in Float 1.12
No of funds 5
Yield 0.53
Book Value 1.3
U/D Vol ratio 1
LTDebt / Equity
Alpha -0.13
Beta 0.95

Lincoln Pharmaceuticals

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 44.08%42.05%42.08%
Foreign Portfolio Investors 0.64%0.77%0.95%
Financial Institutions/ Banks
Individual Investors 39.12%38.67%38.88%
Others 16.16%18.51%18.09%

Lincoln Pharmaceuticals Management

Name Designation
Mr. Kishor M Shah Chairman
Mr. Mahendra G Patel Managing Director
Mr. Hashmukh I Patel Whole Time Director
Mr. Munjal M Patel Whole Time Director
Mr. Ashish R Patel Whole Time Director
Mr. Arvind G Patel Director
Mr. Rajnikant G Patel Director
Mr. Ishwarlal A Patel Independent Director
Mr. Pirabhai R Suthar Independent Director
Mr. Meha M Patel Independent Director
Mr. Saurin J Parikh Independent Director

Lincoln Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lincoln Pharmaceuticals Corporate Action

Date Purpose Remarks
2022-08-09 Quarterly Results
2022-05-19 Audited Results & Dividend
2022-02-10 Quarterly Results
2021-11-11 Quarterly Results
2021-10-05 Others inter-alia, 1) To issue/ allot equity shares to the eligible shareholders of Lincoln Parenteral Ltd. pursuant to Scheme of Amalgamation. per share(15%)Dividend

Lincoln Pharmaceuticals MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Lincoln Pharmaceuticals FAQs

What is Share Price of Lincoln Pharmaceuticals ?

Lincoln Pharmaceuticals share price is ₹281 As on 30 September, 2022 | 02:31

What is the Market Cap of Lincoln Pharmaceuticals ?

The Market Cap of Lincoln Pharmaceuticals is ₹564.6 Cr As on 30 September, 2022 | 02:31

What is the P/E ratio of Lincoln Pharmaceuticals ?

The P/E ratio of Lincoln Pharmaceuticals is 8.5 As on 30 September, 2022 | 02:31

What is the PB ratio of Lincoln Pharmaceuticals ?

The PB ratio of Lincoln Pharmaceuticals is 1.3 As on 30 September, 2022 | 02:31

Q1FY23